Kairos Pharma Ltd. (KAPA)
0.505
+0.03
(+6.65%)
USD |
NYAM |
Nov 03, 16:00
0.486
-0.02
(-3.76%)
After-Hours: 20:00
Kairos Pharma Market Cap : 1.546M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.546M |
| November 02, 2026 | 1.449M |
| October 30, 2026 | 1.622M |
| October 29, 2026 | 1.653M |
| October 28, 2026 | 1.601M |
| October 27, 2026 | 1.622M |
| October 26, 2026 | 1.641M |
| October 23, 2026 | 1.709M |
| October 22, 2026 | 1.665M |
| October 21, 2026 | 1.765M |
| October 20, 2026 | 1.786M |
| October 19, 2026 | 1.745M |
| October 16, 2026 | 1.840M |
| October 15, 2026 | 2.052M |
| October 14, 2026 | 2.274M |
| October 13, 2026 | 2.536M |
| October 12, 2026 | 2.546M |
| October 09, 2026 | 2.480M |
| October 08, 2026 | 2.936M |
| October 07, 2026 | 2.663M |
| October 06, 2026 | 3.520M |
| October 05, 2026 | 4.744M |
| October 02, 2026 | 4.774M |
| October 01, 2026 | 4.774M |
| September 30, 2026 | 5.019M |
| Date | Value |
|---|---|
| September 29, 2026 | 5.080M |
| September 28, 2026 | 5.142M |
| September 25, 2026 | 5.264M |
| September 24, 2026 | 5.417M |
| September 23, 2026 | 5.295M |
| September 22, 2026 | 5.448M |
| September 21, 2026 | 5.478M |
| September 18, 2026 | 5.295M |
| September 17, 2026 | 5.540M |
| September 16, 2026 | 5.540M |
| September 15, 2026 | 5.662M |
| September 14, 2026 | 5.631M |
| September 11, 2026 | 5.380M |
| September 10, 2026 | 5.142M |
| September 09, 2026 | 5.080M |
| September 08, 2026 | 5.417M |
| September 04, 2026 | 5.631M |
| September 03, 2026 | 5.111M |
| September 02, 2026 | 4.836M |
| September 01, 2026 | 5.050M |
| August 31, 2026 | 5.142M |
| August 28, 2026 | 5.080M |
| August 27, 2026 | 5.163M |
| August 26, 2026 | 38.99M |
| August 25, 2026 | 37.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.541B |
| Alnylam Pharmaceuticals, Inc. | 21.41B |
| Anika Therapeutics, Inc. | 260.30M |
| Savara, Inc. | 975.65M |
| Vericel Corp. | 2.103B |
Market Cap Related Metrics
| Price to Book Value | 0.3688 |
| Price | 0.505 |
| Earnings Yield | -385.7% |